• Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Bids Goodbye to Bay Area R&D Shop More...
• Zurex Pharma Raises $6.2 Million More...
• InterMune, Inc. (ITMN) Sells Actimmune to Vidara for $55 Million More...
• Merck KGaA (MKGAF.PK) Buys Interest in Israeli Start-up QLight Nanotech More...
• Suneva Medical Acquires Product Portfolio from Spear Pharmaceuticals, Inc. More...
• Codexis, Inc. (CDXS) Announces 3-Year Extension of Collaboration Deal With Merck & Co., Inc. (MRK) More...
• Intermountain Healthcare and Myriad Genetics, Inc. (MYGN) Enter Into Research Collaboration Agreement More...
• 3D Biomatrix Signs Distribution Agreements in North America and Asia More...
• Link Technologies Ltd Announces Partnership With American International Chemical More...
• Genpact Signs Business Process Management Engagement with Dr. Reddy's Laboratories Ltd. (RDY) More...
• Paratek Pharmaceuticals, Inc. Announces Appointments of Dennis Molnar as Chief Executive Officer and Director and ofDr. Evan Loh as Chief Medical Officer and Chairman of the Board of Directors More...
• Talon Therapeutics, Inc. (TLON.OB) Appoints Head of Commercial Operations and Planning More...
• e-Therapeutics plc' Preliminary Results for the Year Ended 31 January 2012 More...
• Servier Trial In France Delayed Over Appeal More...
• PRA International, Inc. (PRAI) Expands Operations in Europe More...
• FDA Staff Shoots Down Pfizer Inc. (PFE) Rare Disease Drug More...
• Astellas Pharma Inc. (YPH.BE)/Medivation, Inc. (MDVN) File Prostate Cancer Drug in USA More...
• Apricus Biosciences (APRI) Granted Regulatory Guidance With FDA for MycoVa™ for the Treatment of Onychomycosis More...
• Chelsea Therapeutics, Inc. (CHTP) Completes End-of-Review Meeting With FDA for Northera™ (droxidopa) Capsules New Drug Application More...
• Bayer HealthCare Pharmaceuticals (BAYA.F), Onyx Pharmaceuticals, Inc. (ONXX) Cancer Drug Fails in Late-stage Study More...
• Johnson & Johnson (JNJ)'s Simponi Helps Colitis Patients in Trial More...
• Eli Lilly and Company (LLY)'s Diabetes Drug Meets Mid-stage Trial Goal More...
• Merck & Co., Inc. (MRK) Vaccine Fears Confirmed in Newest Study More...
• Sucampo Pharmaceuticals, Inc. Reports Positive Data from Lubiprostone Drug Trials More...
• Snoring Linked to Cancer, University of Wisconsin-Madison Study More...
• Edible "Stop Signs" Remind Us to Eat Less, Cornell University and Yale University Study More...
• Cholesterol-Lowering Drugs May Slow Prostate Growth, Duke University Medical Center Study More...
• Vigorous Exercise Might Keep Psoriasis at Bay, Brigham and Women's Hospital Study More...
• Routine PSA Tests for Prostate Cancer Not Good for Health: U.S. Advisers More...
• Elite Pharmaceuticals, Inc. (ELI) Announces Issuance of U.S. Patent for Abuse Resistant Oral Dosage Formulation More...
• Suven Life Sciences Ltd Secures 4 Product Patents for their NCEs in Japan, Australia, Europe and Eurasia More...
• Pivotal Therapeutics Inc. Announces First Prescription Sales in the United States More...
• Zurex Pharma Raises $6.2 Million More...
• InterMune, Inc. (ITMN) Sells Actimmune to Vidara for $55 Million More...
• Merck KGaA (MKGAF.PK) Buys Interest in Israeli Start-up QLight Nanotech More...
• Suneva Medical Acquires Product Portfolio from Spear Pharmaceuticals, Inc. More...
• Codexis, Inc. (CDXS) Announces 3-Year Extension of Collaboration Deal With Merck & Co., Inc. (MRK) More...
• Intermountain Healthcare and Myriad Genetics, Inc. (MYGN) Enter Into Research Collaboration Agreement More...
• 3D Biomatrix Signs Distribution Agreements in North America and Asia More...
• Link Technologies Ltd Announces Partnership With American International Chemical More...
• Genpact Signs Business Process Management Engagement with Dr. Reddy's Laboratories Ltd. (RDY) More...
• Paratek Pharmaceuticals, Inc. Announces Appointments of Dennis Molnar as Chief Executive Officer and Director and ofDr. Evan Loh as Chief Medical Officer and Chairman of the Board of Directors More...
• Talon Therapeutics, Inc. (TLON.OB) Appoints Head of Commercial Operations and Planning More...
• e-Therapeutics plc' Preliminary Results for the Year Ended 31 January 2012 More...
• Servier Trial In France Delayed Over Appeal More...
• PRA International, Inc. (PRAI) Expands Operations in Europe More...
• FDA Staff Shoots Down Pfizer Inc. (PFE) Rare Disease Drug More...
• Astellas Pharma Inc. (YPH.BE)/Medivation, Inc. (MDVN) File Prostate Cancer Drug in USA More...
• Apricus Biosciences (APRI) Granted Regulatory Guidance With FDA for MycoVa™ for the Treatment of Onychomycosis More...
• Chelsea Therapeutics, Inc. (CHTP) Completes End-of-Review Meeting With FDA for Northera™ (droxidopa) Capsules New Drug Application More...
• Bayer HealthCare Pharmaceuticals (BAYA.F), Onyx Pharmaceuticals, Inc. (ONXX) Cancer Drug Fails in Late-stage Study More...
• Johnson & Johnson (JNJ)'s Simponi Helps Colitis Patients in Trial More...
• Eli Lilly and Company (LLY)'s Diabetes Drug Meets Mid-stage Trial Goal More...
• Merck & Co., Inc. (MRK) Vaccine Fears Confirmed in Newest Study More...
• Sucampo Pharmaceuticals, Inc. Reports Positive Data from Lubiprostone Drug Trials More...
• Snoring Linked to Cancer, University of Wisconsin-Madison Study More...
• Edible "Stop Signs" Remind Us to Eat Less, Cornell University and Yale University Study More...
• Cholesterol-Lowering Drugs May Slow Prostate Growth, Duke University Medical Center Study More...
• Vigorous Exercise Might Keep Psoriasis at Bay, Brigham and Women's Hospital Study More...
• Routine PSA Tests for Prostate Cancer Not Good for Health: U.S. Advisers More...
• Elite Pharmaceuticals, Inc. (ELI) Announces Issuance of U.S. Patent for Abuse Resistant Oral Dosage Formulation More...
• Suven Life Sciences Ltd Secures 4 Product Patents for their NCEs in Japan, Australia, Europe and Eurasia More...
• Pivotal Therapeutics Inc. Announces First Prescription Sales in the United States More...
0 comments